Saturday 17 October 2026
Export KMDA’s income statement to Excel — free account
Kamada Ltd.
KMDA Healthcare Drug Manufacturers Specialty & Generic
Kamada Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $180.5 million, up 12.1% from fiscal 2024. In the quarter to June 2026, revenue grew 22.7%, EPS grew 23.1%, free cash flow grew 165.7% and total debt fell 38.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
7.77
0.06
−0.77%
Follow KMDA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
7.86% | 7.64% | 7.97% | 8.40% | |
Piotroski F-Score |
7 | 7 | 7 | 7 | |
| 5.61% | 5.38% | 5.37% | 5.92% | ||
ROIC |
8.51% | 8.06% | 8.06% | 8.47% | |
Return on Tangible Assets |
11.17% | 10.80% | 11.26% | 11.49% | |
Average Days of Receivables |
73.77 | 66.06 | 81.67 | 80.98 | |
Free Cash Flow per Share |
0.31 | 0.27 | 0.28 | 0.45 | |
Free Cash Flow |
18.34 | 15.65 | 16.36 | 26.32 | |
Capital Expenditures |
(9.99) | (9.84) | (9.35) | (9.44) | |
| Other line items | |||||
Cash ROIC |
5.27% | 4.42% | 4.77% | 7.61% | |
Accounts Receivable Turnover |
6.22 | 6.04 | 4.87 | 4.93 | |
Accounts Payable Turnover |
3.44 | 2.86 | 2.35 | 3.05 | |
Inventory Turnover |
1.25 | 1.27 | 1.31 | 1.34 | |
Average Days of Payables |
127.41 | 124.00 | 160.01 | 130.78 | |
Days of Inventory on Hand |
317.10 | 297.97 | 291.69 | 279.29 | |
Tax Rate |
(0.04) | (0.14) | (0.08) | (0.17) | |
Research and Development Expense of Revenue |
7.31% | 7.20% | 6.02% | 5.17% | |
Selling, General and Administrative Expense of Revenue |
20.22% | 20.60% | 21.17% | 21.15% | |
Share Based Compensation of Revenue |
0.32% | 0.47% | 0.81% | 1.09% | |
Interest Coverage |
34.96 | 30.36 | 29.52 | 26.79 | |
Operating CF/Net income |
1.39 | 1.26 | 1.26 | 1.61 | |
Depreciation/Fixed assets |
0.40 | 0.36 | 0.37 | 0.35 | |
Capex/Depreciation |
(0.66) | (0.66) | (0.62) | (0.62) | |
Revenue per Share |
2.97 | 3.13 | 3.08 | 3.31 | |
Operating CF per Share |
0.48 | 0.44 | 0.44 | 0.62 | |
Capex per Share |
(0.17) | (0.17) | (0.16) | (0.16) | |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.05 |
Columns are period end dates